Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yea-Jiuen Liang"'
Autor:
Wen-Yu Cheng, Chiung-Chyi Shen, Yea-Jiuen Liang, Ming-Tsang Chiao, Yi-Chin Yang, Wan-Yu Hsieh, Cheng-Hui Lin, Jun-Peng Chen
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-17 (2023)
Abstract Glioblastoma (GBM), a prevalent and malignant brain tumor, poses a challenge in surgical resection due to its invasive nature within the brain parenchyma. CDKN1A (p21, Waf-1), a cyclin-dependent kinase inhibitor, plays a pivotal role in regu
Externí odkaz:
https://doaj.org/article/87ecafea9d3d4c4d8f3d680f780b38f1
Autor:
Chiung-Chyi Shen, Wen-Yu Cheng, Chung-Hsin Lee, Xue-Jun Dai, Ming-Tsang Chiao, Yea-Jiuen Liang, Wan-Yu Hsieh, Tsuo-Fei Mao, Guo-Shi Lin, Shou-Ren Chen, Bai-Shuan Liu, Jun-Peng Chen
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Abstract Background It has previously been shown that bevacizumab, when added to chemotherapy, improved overall survival in several cancers. In glioblastoma multiforme (GBM), bevacizumab increased progression-free survival and it is widely used for t
Externí odkaz:
https://doaj.org/article/88900556b9e0469590426a29b0a895cb
Autor:
Tsuo-Fei Mao, Ming-Tsang Chiao, Wan-Yu Hsieh, Shou-Ren Chen, Jun-Peng Chen, Chiung-Chyi Shen, Bai-Shuan Liu, Chung-Hsin Lee, Guo-Shi Lin, Yea-Jiuen Liang, Wen-Yu Cheng, Xue-Jun Dai
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-13 (2020)
Background It has previously been shown that bevacizumab, when added to chemotherapy, improved overall survival in several cancers. In glioblastoma multiforme (GBM), bevacizumab increased progression-free survival and it is widely used for tumor recu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a011f1627c8efe51e2f8e7041d5afea
http://europepmc.org/articles/PMC7391574
http://europepmc.org/articles/PMC7391574
Autor:
Shen, Chiung-Chyi, Cheng, Wen-Yu, Chung-Hsin Lee, Dai, Xue-Jun, Ming-Tsang Chiao, Yea-Jiuen Liang, Wan-Yu Hsieh, Tsuo-Fei Mao, Lin, Guo-Shi, Shou-Ren Chen, Bai-Shuan Liu, Jun-Peng Chen
Additional file 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b0812928bb3705a2baa1aa73b660270
Autor:
Ming-Tsang Chiao, Wen-Yu Cheng, Yea-Jiuen Liang, Yi-Chin Yang, Chiung-Chyi Shen, Chiou-Ying Yang
Publikováno v:
Molecular Biology Reports
Luteolin (3′,4′,5,7-tetrahydroxyflavone) is a common flavonoid in many types of plants and has several beneficial biological effects, including anti-inflammation, anti-oxidant, and anti-cancer properties. However, the detail mechanisms of luteoli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::144123478db02bca4469461b89524081
http://europepmc.org/articles/PMC3751389
http://europepmc.org/articles/PMC3751389